National Graphite Corp. Stock Analysis NGRC
National Graphite Corp. is an exploration company, which engages in the exploration of gold, silver, and related minerals. The company is headquartered in Dusseldorf, Nordrhein-Westfalen. The company went IPO on 2009-06-30. The firm is pursuing the commercial development of a drug candidate, elafin, for the treatment of postoperative inflammatory complications. Elafin is a human identic protein. The firm operates in Germany, in collaboration with clinical-stage companies that develop new biological entities or new therapeutically platforms in the treatment for various diseases, rare diseases and diseases with unmet needs. Biotech Development Corp. is the Company's subsidiary. As of February 28, 2015, the Company had not generated any revenues.
Read More National Graphite Corp (NGRC) Chart
Key Statistics of National Graphite Corp (NGRC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.03Volume
1000.00P/E Ratio (TTM)
-52 Week Range
Market Cap
3.55MAvg. Volume
1575.71Dividend Yield
-Financial Metrics & Statements of National Graphite Corp (NGRC)
FAQ's for National Graphite Corp (NGRC)
- According to Musaffa’s Shariah screening methodology, National Graphite Corp (NGRC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.